A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma
Public ClinicalTrials.gov record NCT03890666. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CONNected Electronic Inhalers Asthma Control Trial 1 ("CONNECT 1"), a 12-Week Treatment, Multicenter, Open-Label, Randomized, Parallel Group Comparison, Feasibility Study to Evaluate the Effectiveness of the Albuterol eMDPI Digital System, to Optimize Outcomes in Patients at Least 13 Years of Age or Older With Asthma
Study identification
- NCT ID
- NCT03890666
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Enrollment
- 333 participants
Conditions and interventions
Conditions
Interventions
- Albuterol eMDPI DS Drug
- albuterol Drug
Drug
Eligibility (public fields only)
- Age range
- 13 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 25, 2020
- Primary completion
- Oct 3, 2021
- Completion
- Oct 3, 2021
- Last update posted
- Mar 18, 2026
2020 – 2021
United States locations
- U.S. sites
- 29
- U.S. states
- 18
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 14232 | Birmingham | Alabama | 35209 | — |
| Teva Investigational Site 14302 | Los Angeles | California | 90025 | — |
| Teva Investigational Site 14301 | Stockton | California | 95207-6204 | — |
| Teva Investigational Site 14236 | Colorado Springs | Colorado | 80907 | — |
| Teva Investigational Site 14198 | Denver | Colorado | 80206 | — |
| Teva Investigational Site 14220 | New Haven | Connecticut | 06510 | — |
| Teva Investigational Site 14197 | Aventura | Florida | 33180 | — |
| Teva Investigational Site 14306 | Miami | Florida | 33186 | — |
| Teva Investigational Site 14215 | Sarasota | Florida | 34239 | — |
| Teva Investigational Site 14304 | Albany | Georgia | 31707 | — |
| Teva Investigational Site 14195 | Savannah | Georgia | 31406 | — |
| Teva Investigational Site 14217 | Evanston | Illinois | 60201 | — |
| Teva Investigational Site 14218 | Springfield | Illinois | 62704 | — |
| Teva Investigational Site 14305 | Louisville | Kentucky | 40215 | — |
| Teva Investigational Site 14191 | Owensboro | Kentucky | 42301 | — |
| Teva Investigational Site 14233 | Ann Arbor | Michigan | 48109 | — |
| Teva Investigational Site 14207 | Bellevue | Nebraska | 68123-4303 | — |
| Teva Investigational Site 14221 | New York | New York | 10461 | — |
| Teva Investigational Site 14234 | Chapel Hill | North Carolina | 27599 | — |
| Teva Investigational Site 14187 | Cincinnati | Ohio | 45231 | — |
| Teva Investigational Site 14210 | Philadelphia | Pennsylvania | 19140 | — |
| Teva Investigational Site 14208 | Pittsburgh | Pennsylvania | 15241 | — |
| Teva Investigational Site 14200 | Providence | Rhode Island | 02906 | — |
| Teva Investigational Site 14300 | Charleston | South Carolina | 29407 | — |
| Teva Investigational Site 14196 | Greenville | South Carolina | 29607 | — |
| Teva Investigational Site 14188 | San Antonio | Texas | 78207 | — |
| Teva Investigational Site 14192 | San Antonio | Texas | 78229 | — |
| Teva Investigational Site 14189 | San Antonio | Texas | 78251 | — |
| Teva Investigational Site 14190 | Greenfield | Wisconsin | 53228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03890666, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 18, 2026 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03890666 live on ClinicalTrials.gov.